CeQur lands CE Mark for its PaQ continuous insulin delivery device

Thu, 11/29/2012 - 1:42pm
Mass Device

CeQur SA receives CE Marked approval to commercialize PaQ insulin delivery devices in the European market.

CeQur logo

CeQur SA received CE Mark approval to commercialize its PaQ insulin delivery devices in the European market, the company reported this week.

The PaQ insulin delivery system features a disposable insulin-infuser reservoir attached to a reusable insulin monitor and provides 3 days of continuous basal insulin delivery and on-demand bolus insulin for individuals with Type II diabetes, the company said.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.